510(k) Report

FDA applicant

Medtronic Neurosurgery

Goleta, CA28 decisions2001–202511 recalls

FDA records 28 decisions for Medtronic Neurosurgery (Goleta, CA) from 2001 to 2025: 27 510(k) clearances and 1 De Novo grant. Most are in product codes JXG (Shunt, Central Nervous System And Components) and GXQ (Dura Substitute). Since 2016 its 510(k)s took a median of 136 days from receipt to decision, against 123 for FDA’s reviews in the same codes and years. Its devices cite 64 predicates, 25 of them its own earlier devices. 11 recalls are linked to its devices, 1 Class I.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, neurology panel, where it files most

How often FDA has decided Medtronic Neurosurgery’s devices, and how often a recall has named them.

FDA decisions per year

1in 2025

2007: 12008: 32009: 12011: 12013: 12014: 12016: 22018: 12021: 12024: 12025: 1
2007high 3 (2008) · low 0 (2010)2026

2026 so far, outlined.

Recalls per year

1in 2023

2013: 12017: 3, 1 Class I2018: 12020: 32021: 22023: 1
2007high 3 (2017) · low 0 (2007)2026

Class I Class II/III not classified

FIG. 1 — Medtronic Neurosurgery by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Medtronic Neurosurgery’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report